Free Trial

Eyepoint Pharmaceuticals (EYPT) SEC Filings & 10K Form

Eyepoint Pharmaceuticals logo
$10.17 -0.19 (-1.83%)
Closing price 04:00 PM Eastern
Extended Trading
$10.38 +0.21 (+2.02%)
As of 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Eyepoint Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/11/2025
3:06 PM
Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2025
3:06 PM
Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2025
3:07 PM
Eyepoint Pharmaceuticals (Issuer)
Zaderej Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2025
6:30 AM
Eyepoint Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SCHEDULE 13G/A
06/25/2025
4:13 PM
Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
3:06 PM
Eyepoint Pharmaceuticals (Issuer)
Zaderej Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form DEFA14A
05/07/2025
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
3:10 PM
Eyepoint Pharmaceuticals (Filer)
Form DEFA14A
03/20/2025
3:06 PM
Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:05 PM
Eyepoint Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2025
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
8:00 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:37 PM
Eyepoint Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/12/2025
8:33 AM
Adage Capital Management, L.P. (Filed by)
Eyepoint Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/11/2025
5:19 PM
Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
5:19 PM
Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
5:19 PM
Elston George (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
11:58 AM
Eyepoint Pharmaceuticals (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
01/13/2025
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:11 PM
Eyepoint Pharmaceuticals (Issuer)
Sanders Reginald J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
3:14 PM
Eyepoint Pharmaceuticals (Issuer)
Sanders Reginald J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:03 PM
Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM
Eyepoint Pharmaceuticals (Issuer)
Landis John B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM
Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM
Elston George (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM
Eyepoint Pharmaceuticals (Issuer)
Ribeiro Ramiro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM
DICICCO WENDY F (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM
Duty Stuart (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:04 PM
ANDO GORAN (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:05 PM
Eyepoint Pharmaceuticals (Issuer)
Zaderej Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:05 PM
Eyepoint Pharmaceuticals (Issuer)
Hassan Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
2:10 PM
Cormorant Asset Management, LP (Filed by)
Eyepoint Pharmaceuticals (Subject)
Form SC 13G/A
11/12/2024
1:31 PM
Eyepoint Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
8:33 AM
Adage Capital Management, L.P. (Filed by)
Eyepoint Pharmaceuticals (Subject)
Form SC 13G/A
11/07/2024
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
11/06/2024
7:54 AM
Eyepoint Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G
11/04/2024
10:57 AM
Eyepoint Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
3:16 PM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
11:51 AM
Eyepoint Pharmaceuticals (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
10/30/2024
3:20 PM
Eyepoint Pharmaceuticals (Filer)
Form 424B5
10/28/2024
4:17 PM
Eyepoint Pharmaceuticals (Filer)
Form 424B5
10/28/2024
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
3:34 PM
ADAMIS ANTHONY P (Reporting)
Eyepoint Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Eyepoint Pharmaceuticals (Subject)
Form SC 13G
10/15/2024
10:58 AM
Eyepoint Pharmaceuticals (Subject)
GUYER DAVID R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
3:02 PM
Eyepoint Pharmaceuticals (Issuer)
Hassan Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:02 PM
Eyepoint Pharmaceuticals (Issuer)
Hassan Fred (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/04/2024
6:05 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
3:32 PM
DICICCO WENDY F (Reporting)
Eyepoint Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2024
11:15 PM
Eyepoint Pharmaceuticals (Filer)
Form EFFECT
08/08/2024
3:42 PM
Eyepoint Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/08/2024
3:46 PM
Eyepoint Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2024
6:00 AM
Eyepoint Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:47 PM
Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:24 PM
Eyepoint Pharmaceuticals (Issuer)
GUYER DAVID R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:EYPT) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners